m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00507)
Target Name | hsa-miR-99a-5p | ||||
---|---|---|---|---|---|
Gene Name | hsa-miR-99a-5p |
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
hsa-miR-99a-5p
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 14 (METTL14) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL14, an m6A RNA methyltransferase downregulated in ESCC, suppresses TRIB2 expression via hsa-miR-99a-5p-mediated degradation of TRIB2 mRNA by targeting its 3' untranslated region, whereas TRIB2 induces ubiquitin-mediated proteasomal degradation of METTL14 in a COP1-dependent manner. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Esophageal squamous cell carcinoma | ICD-11: 2B70.1 | ||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Cell Process | Proteasome pathway degradation | |||
In-vitro Model | TE-1 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 |
KYSE-410 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1352 | |
KYSE-150 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1348 | |
HET-1A | Normal | Homo sapiens | CVCL_3702 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_6898 | |
CVCL_E307 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_E307 | |
In-vivo Model | Fresh PDX tumor samples collected from two established PDX models (PDX #07 with high TRIB2 expression and PDX #12 with low TRIB2, passages three to four) were minced and subcutaneously implanted into the flanks of 3- to 4-week-old female BALB/c nude mice (Jiesijie Laboratory Animals). | |||
Oral cavity/oesophagus/stomach in situ carcinoma [ICD-11: 2E60]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL14, an m6A RNA methyltransferase downregulated in ESCC, suppresses TRIB2 expression via hsa-miR-99a-5p-mediated degradation of TRIB2 mRNA by targeting its 3' untranslated region, whereas TRIB2 induces ubiquitin-mediated proteasomal degradation of METTL14 in a COP1-dependent manner. | |||
Responsed Disease | Esophageal squamous cell carcinoma [ICD-11: 2B70.1] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Cell Process | Proteasome pathway degradation | |||
In-vitro Model | TE-1 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1759 |
KYSE-410 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1352 | |
KYSE-150 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_1348 | |
HET-1A | Normal | Homo sapiens | CVCL_3702 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_6898 | |
CVCL_E307 | Esophageal squamous cell carcinoma | Homo sapiens | CVCL_E307 | |
In-vivo Model | Fresh PDX tumor samples collected from two established PDX models (PDX #07 with high TRIB2 expression and PDX #12 with low TRIB2, passages three to four) were minced and subcutaneously implanted into the flanks of 3- to 4-week-old female BALB/c nude mice (Jiesijie Laboratory Animals). | |||
References